What Amneal Pharmaceuticals, Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 4 | 7 |
| Total trades | 14 | 79 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 79 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Buchi J Kevin | Director | Sep 17 | Gift · G | −20,445 | — | — | 75,077 |
| Buchi J Kevin | Director | Sep 11 | Exercise / conversion · M | +20,445 | $14.45 | +$295K | 95,522 |
| Boyer Andrew S | Executive Vice President | Sep 01 | Gift · G | −80,000 | — | — | 193,646 |
| Boyer Andrew S | Executive Vice President | Aug 21 | Gift · G | −152,426 | — | — | 273,646 |
| Kiely John | Director | Aug 13 | Gift · G | −10,000 | — | — | 200,252 |
| Kiely John | Director | Aug 13 | Open-market sale · S | −50,000 | $17.64 | −$882K | 210,252 |
| Daly Jason B. | EVP, Chief Legal Officer | Aug 12 | Open-market sale · S | −210,000 | $17.40 | −$3.65M | 35,171 |
| Shah Nikita | Executive Vice President | Aug 12 | Open-market sale · S | −146,403 | $17.51 | −$2.56M | 253,390 |
| Buchi J Kevin | Director | Aug 11 | Exercise / conversion · M | −168,573 | $17.18 | −$2.9M | 93,499 |
| Daly Jason B. | EVP, Chief Legal Officer | Aug 11 | Open-market sale · S | −6,613 | $17.70 | −$117K | 245,171 |
| Patel Tushar Bhikhubhai | 10% owner | Aug 10 | Grant / award · A | +12,763,469 | — | — | 61,341,678 |
| Patel Chirag K. | President & Co-CEO | Aug 10 | Grant / award · A | +6,381,734 | — | — | 6,381,734 |
| Patel Chintu | Co-CEO | Aug 10 | Grant / award · A | +6,381,734 | — | — | 6,381,734 |
| Patel Gautam | Director | Aug 10 | Grant / award · A | +283,632 | — | — | 283,632 |
| Autor Deborah M. | Director | May 11 | Open-market sale · S | −34,819 | $12.94 | −$451K | 93,660 |
| Patel Gautam | Director | May 07 | Exercise / conversion · M | +34,819 | — | — | 1,643,963 |
| Yanai Shlomo | Director | May 07 | Exercise / conversion · M | +34,819 | — | — | 320,804 |
| Meister Paul M | Director | May 07 | Exercise / conversion · M | +48,747 | — | — | 832,800 |
| Nark Ted C | Director | May 07 | Exercise / conversion · M | +34,819 | — | — | 325,848 |
| Kiely John | Director | May 07 | Exercise / conversion · M | +34,819 | — | — | 260,252 |
Loading...
